A genetic variant that predisposes people to developing a lethal form of tuberculosis (TB), tuberculous meningitis, if they are infected with a strain of TB known as the Beijing strain has been identified by the researchers working in Vietnam.
The research underlines the importance of studying both sides of the complex host-pathogen interaction and its role in susceptibility to disease.
TB, which kills over 2 million people each year, is caused by the bacterium Mycobacterium tuberculosis. It is estimated that well over 2 million people are infected with M. tuberculosis, though the majority will never show symptoms.
Some will develop a latent infection, with symptoms only showing if they become sick or immunocompromised, for example through HIV infection.
A small number will develop an active TB infection, usually in their lungs, occasionally progressing to "disseminated TB" - a condition in which failure of the immune system to control the infection allows its spread to other parts of the body.
Some of the risk factors that determine whether individuals develop active TB following exposure are well known; these include HIV infection, malnutrition and smoking.
In the study, Caws and her colleagues have shown that the predisposition to developing TB meningitis appears to be strongest in people who carry the variant of TLR2 and who are infected with the specific Beijing strain of TB.
"We are seeing an increasing number of cases of the Beijing strain worldwide, a strain that is becoming more and more resistant to drugs," said Dr Caws.
"Our findings are important because they show that we need to look at both the patient's susceptibility to the disease and the genetics of the pathogen that is infecting them at the same time. Many studies have shown a genetic association with disease in one population but the finding has not been repeated in different populations. This might be not only because of ethnic differences in the population, but also because the pathogen populations are different.
"Understanding the mechanisms that influence our susceptibility to infectious diseases may allow us to develop more sophisticated and targeted treatments and vaccines. This is particularly important in this era of emerging 'untreatable' bacterial infections due to antibiotic resistance," she added.
The study has been published in the journal PLoS Pathogens.